BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21458316)

  • 21. Celebrating the death of PSA screening?
    Gomella LG
    Can J Urol; 2011 Dec; 18(6):5987. PubMed ID: 22166323
    [No Abstract]   [Full Text] [Related]  

  • 22. First year of mass screening for prostatic cancer in Yaizu city.
    Kawabe K; Ishikawa A
    Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 24. PSA updated: still relevant in the new millennium?
    Shah JB; Reese AC; McKiernan JM; Benson MC
    Eur Urol; 2005 Apr; 47(4):427-32. PubMed ID: 15774237
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PSA level--is 4.0 ng/ml as upper limit too high].
    Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 28. New Zealand should introduce population screening for prostate cancer using PSA testing: yes.
    Smart R
    J Prim Health Care; 2009 Dec; 1(4):319-20. PubMed ID: 20690342
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Raaijmakers R; Wildhagen MF; Ito K; Pàez A; de Vries SH; Roobol MJ; Schröder FH
    Urology; 2004 Feb; 63(2):316-20. PubMed ID: 14972481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
    Hugosson J; Aus G; Lilja H; Lodding P; Pihl CG; Pileblad E
    J Urol; 2003 May; 169(5):1720-3. PubMed ID: 12686817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What can be concluded from the ERSPC and PLCO trial data?
    Studer UE; Collette L
    Urol Oncol; 2010; 28(6):668-9. PubMed ID: 21062648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
    Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate specific antigen screening and active surveillance in the elderly.
    Konety BR
    J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
    [No Abstract]   [Full Text] [Related]  

  • 35. [Elevated PSA--what to do?].
    Machemer H; Rohde D
    MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
    [No Abstract]   [Full Text] [Related]  

  • 36. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 37. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M; Ardaillou R;
    Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AUA issues a policy report on PSA monitoring. The American Urological Association.
    Scott Morey S
    Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.